Search Thermo Fisher Scientific
Search Thermo Fisher Scientific
Genomic techniques for biomarker discovery enable the identification of specific biomarkers that can serve as indicators for prediction, prognosis, and treatment of cancer in the future. Through analysis of genetic variations and expression patterns, these techniques provide valuable insights that can lead to personalized cancer therapies and improved patient outcomes.
Our Applied Biosystems TaqMan Gene Expression assays and arrays enable researchers to reliably detect and quantitate the expression levels of common cancer biomarkers in addition to novel biomarkers identified in high-throughput transcriptomic studies that require verification, which have been used in studies of multiple different types of cancer (1,2,3).
Figure 1 highlights the leading oncology research areas and demonstrates how TaqMan Gene Expression predesigned assays can be highly relevant to these specific topics. With thousands of available TaqMan Assays, each supported by scientific citations, Thermo Fisher Scientific offers a comprehensive solution for your oncology research needs. No matter which oncology type you are studying, we have the assays necessary to help drive your research forward. Explore the Gene Expression assays tailored to your specific research topic below.
Click the plus sign to view the list of recommended predesigned TaqMan Gene Expression assays for each cancer type.
If you are unable to find the recommended assay for your specific gene targets in the provided lists above, or if you require assays for other species, we recommend utilizing our TaqMan predesigned assay search tool for a comprehensive selection of available options.
To start your search, enter keywords such as gene symbol or name, RefSeq number, disease, pathway, or TaqMan Assay ID number. Choose gene expression application and species to further refine your search.
Search over 2.8 million gene expression assays here:
What chromosome position are you interested in?
Genome Version: Build GRCh38 for
Discover the pivotal role of microRNAs (miRNAs) in cancer research with our expertly crafted miRNA workflow solutions. miRNAs regulate gene expression at the post-transcriptional level, crucial for understanding cancer biology. With over 30K predesigned assays and custom design options, TaqMan miRNA Assays are your go-to for miRNA biomarker identification and investigation. Designed with our proprietary bioinformatics pipeline and backed by the TaqMan Assay Guarantee, these assays have been widely used in cancer studies (4,5,6,7).
Our intuitive platform simplifies finding and purchasing TaqMan miRNA Assays.
Search over 30K microRNA assays here:
Copy number variation (CNV) is a key biomarker in cancer development and progression, affecting gene expression and cancer susceptibility. With over 1.8M predesigned assays and custom design options, TaqMan Copy Number Assays are ideal for CNV biomarker identification and investigation. Designed with our proprietary bioinformatics pipeline and backed by the TaqMan Assay Guarantee, these assays are widely used in various cancer studies (8,9).
Our intuitive platform simplifies finding and purchasing TaqMan CNV Assays.
Search over 1.8 million CNV assays here:
Biomarker | Recommended master mix | TaqMan Assays | Detection and quantification |
Sample preparation kits | Comprehensive Support |
Gene expression | TaqMan Fast Advanced Master Mix
|
QuantStudio real-time PCR systems |
|
How to search and order TaqMan assays
|
|
miRNA | TaqMan Fast Advanced Master Mix | ||||
Predesigned miRNA assays | |||||
Copy number variation | TaqPath ProAmp Master Mix | Predesigned CNV assays |
Biomarker | Recommended master mix |
TaqMan Assays | Detection and quantification |
Sample preparation kits | Comprehensive Support |
Gene expression | Absolute Q Universal DNA Digital PCR Master Mix
|
QuantStudio Absolute Q Digital PCR System-Abs Q | MagMAX Cell-Free DNA Isolation Kit
|
|
|
miRNA |
|||||
Copy number variation | Predesigned CNV assays |
[1] Down-regulation of ERAP1 mRNA expression in non-small cell lung cancer
[2] Characterization of systolic and diastolic function, alongside proteomic profiling, in doxorubicin-induced cardiovascular toxicity in mice
[3] Dual effect of vitamin D3 on breast cancer-associated fibroblasts
[4] miRNA-based biomarkers, therapies, and resistance in Cancer
[5] TaqMan Advanced miRNA cDNA Synthesis Kit to simultaneously study expression of miRNA and mRNA and to detect somatic mutations by qPCR [abstract]
[6] A novel microRNA signature for the detection of melanoma by liquid biopsy
[7] CD204-positive M2-like tumor-associated macrophages increase migration of gastric cancer cells by upregulating miR-210 to reduce NTN4 expression
Q: How do you know if a gene target is associated to a given disease?
A: We used an AI engine to analyze all publicly accessible scientific literature to determine how closely associated each gene target is respective to a disease type. This methodology serves to guide how strongly associated a gene-disease relationship is but is neither exhaustive nor conclusive. This association is intended for research purposes and does not indicate the diagnostic value of the gene target for the disease of interest. Consider the lists provided here as a starting point.
Q: What is the recommended assay?
Recommended products are evaluated by a proprietary bioinformatic algorithm with additional criteria.
Q: Are there assays available for gene targets in another species?
Yes, most TaqMan assays are designed for common species like human, mouse, and rat, but 26 other species may be applicable.
For Research Use Only. Not for use in diagnostic procedures.